Trade Summary

4 days ago, Douglas Richard, serving as Dir at Aldeyra Therapeutics, Inc. (ALDX), purchased 70,000 shares at $1.40 per share, for a total transaction value of $98,000.00. Following this transaction, Douglas Richard now holds 195,000 shares of ALDX.

This purchase represents a 56.00% increase in Douglas Richard's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, March 19, 2026 and publicly disclosed via SEC Form 4 filing on Friday, March 20, 2026, 1 day after the trade was made.

Aldeyra Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.